- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
NSD2 is a conserved driver of metastatic prostate cancer progression ; volume:9 ; number:1 ; day:5 ; month:12 ; year:2018 ; pages:1-14 ; date:12.2018
Nature Communications ; 9, Heft 1 (5.12.2018), 1-14, 12.2018
- Creator
-
Aytes, Alvaro
Giacobbe, Arianna
Mitrofanova, Antonina
Ruggero, Katia
Cyrta, Joanna
Arriaga, Juan
Palomero, Luis
Farran-Matas, Sonia
Rubin, Mark A.
Shen, Michael M.
Califano, Andrea
Abate-Shen, Cory
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-018-07511-4
- URN
-
urn:nbn:de:101:1-2019011919081423576416
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Aytes, Alvaro
- Giacobbe, Arianna
- Mitrofanova, Antonina
- Ruggero, Katia
- Cyrta, Joanna
- Arriaga, Juan
- Palomero, Luis
- Farran-Matas, Sonia
- Rubin, Mark A.
- Shen, Michael M.
- Califano, Andrea
- Abate-Shen, Cory
- SpringerLink (Online service)
Other Objects (12)
Neutrophils are mediators of metastatic prostate cancer progression in bone
PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression
Correction: PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression
Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progression
Pattern of Clinical Progression Until Metastatic Castration-Resistant Prostate Cancer: An Epidemiological Study from the European Prostate Cancer Registry
Primary Tumor Resection Decelerates Disease Progression in an Orthotopic Mouse Model of Metastatic Prostate Cancer
Hypoxia-dependent drivers of melanoma progression
Future therapeutic strategies for metastatic prostate cancer
Leptomeningeal Carcinomatosis of Metastatic Primary Prostate Cancer
Epigenetic Regulation in Prostate Cancer Progression
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer
The outcome of prostate cancer patients treated with curative intent strongly depends on survival after metastatic progression
Neutrophils are mediators of metastatic prostate cancer progression in bone
PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression
Correction: PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression
Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progression
Pattern of Clinical Progression Until Metastatic Castration-Resistant Prostate Cancer: An Epidemiological Study from the European Prostate Cancer Registry
Primary Tumor Resection Decelerates Disease Progression in an Orthotopic Mouse Model of Metastatic Prostate Cancer
Hypoxia-dependent drivers of melanoma progression
Future therapeutic strategies for metastatic prostate cancer
Leptomeningeal Carcinomatosis of Metastatic Primary Prostate Cancer
Epigenetic Regulation in Prostate Cancer Progression
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer
The outcome of prostate cancer patients treated with curative intent strongly depends on survival after metastatic progression
Neutrophils are mediators of metastatic prostate cancer progression in bone
PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression
Correction: PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression
Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progression
Pattern of Clinical Progression Until Metastatic Castration-Resistant Prostate Cancer: An Epidemiological Study from the European Prostate Cancer Registry
Primary Tumor Resection Decelerates Disease Progression in an Orthotopic Mouse Model of Metastatic Prostate Cancer
Hypoxia-dependent drivers of melanoma progression
Future therapeutic strategies for metastatic prostate cancer
Leptomeningeal Carcinomatosis of Metastatic Primary Prostate Cancer
Epigenetic Regulation in Prostate Cancer Progression
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer